Exonate

Foventa Therapeutics

The company develops non-invasive topical eye drops to treat retinal vascular diseases for patients with non-proliferative diabetic retinopathy.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Vantage Biosciences

This clinical-stage biotechnology company develops oral therapies to treat diabetic retinopathy and other inflammatory conditions for patients with diabetic eye disease.

Eyconis

The company develops long-acting ophthalmic medicines for patients with retinal diseases such as wet age-related macular degeneration.

Breye Therapeutics

This biopharmaceutical company develops orally administered medicines for patients with retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.